The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Proteomic Analysis of Waldenstrom Macroglobulinemia
Abstract
To better understand the molecular changes that occur in Waldenstrom macroglobulinemia (WM), we employed antibody-based protein microarrays to compare patterns of protein expression between untreated WM and normal bone marrow controls. Protein expression was defined as a >2-fold or 1.3-fold change in at least 67% of the tumor samples. Proteins up-regulated by >2-fold included Ras family proteins, such as Rab-4 and p62DOK, and Rho family proteins, such as CDC42GAP and ROKα. Other proteins up-regulated by >1.3-fold included cyclin-dependent kinases, apoptosis regulators, and histone deacetylases (HDAC). We then compared the samples of patients with symptomatic and asymptomatic WM and showed similar protein expression signatures, indicating that the dysregulation of signaling pathways occurs early in the disease course. Three proteins were different by >2-fold in symptomatic versus asymptomatic, including the heat shock protein HSP90. Elevated protein expression was confirmed by immunohistochemistry and immunoblotting. Functional significance was validated by the induction of apoptosis and inhibition of proliferation using specific HDAC and HSP90 inhibitors. This study, therefore, identifies, for the first time, multiple novel proteins that are dysregulated in WM, which both enhance our understanding of disease pathogenesis and represent targets of novel therapeutics. [Cancer Res 2007;67(8):3777–8]
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Clontech antibody array has been used in a variety of settings since 2003 (Anderson, et al., 2003,Hatjiharissi, et al., 2007).”
From Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease (2013) · cites this paper as Hatjiharissi, et al., 2007
In the citing paper
“Independent publications report very high validity of differential protein expression, verified with Western blotting, and our preliminary study findings were consistent with this.”
From Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease (2013) · cites this paper as Hatjiharissi, et al., 2007
Citations
Cites
Discordant Protein and mRNA Expression in Lung Adenocarcinomas
Chen, G., Gharib, T. G., Huang, C.-C., Taylor, J. M. G., Misek, D. E., Kardia, S. L. R., Giordano, T. J., Iannettoni, M. D., Orringer, M. B., Hanash, S. M., et al. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200008-mcp200 · Cited by 946
Owen, R. G., Treon, S. P., Al-Katib, A., Fonseca, R., Greipp, P. R., McMaster, M. L., Morra, E., Pangalis, G. A., San Miguel, J. F., Branagan, A. R., et al. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50082 · Cited by 924
Self-citationZhu, H., & Snyder, M. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00005-4 · Cited by 870
Genetics and Cytogenetics of Multiple Myeloma
Fonseca, R., Barlogie, B., Bataille, R., Bastard, C., Bergsagel, P. L., Chesi, M., Davies, F. E., Drach, J., Greipp, P. R., Kirsch, I. R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2876 · Cited by 687
Self-citationAdvances in biology of multiple myeloma: clinical applications
Hideshima, T., Bergsagel, P. L., Kuehl, W. M., & Anderson, K. C. (2004) · Blood · doi:10.1182/blood-2004-01-0037 · Cited by 582
Self-citationHideshima, T., Catley, L., Yasui, H., Ishitsuka, K., Raje, N., Mitsiades, C., Podar, K., Munshi, N. C., Chauhan, D., Richardson, P. G., et al. (2006) · Blood · doi:10.1182/blood-2005-08-3434 · Cited by 422
Self-citationIdentification of the Abl- and rasGAP-Associated 62 kDa Protein as a Docking Protein, Dok
Yamanashi, Y., & Baltimore, D. (1997) · Cell · doi:10.1016/s0092-8674(00)81841-3 · Cited by 345
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance
Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Remstein, E. D., Offord, J. R., Larson, D. R., Plevak, M. F., & Melton, L. J. (2003) · Blood · doi:10.1182/blood-2003-03-0801 · Cited by 325
Antimyeloma activity of heat shock protein-90 inhibition
Mitsiades, C. S. (2005) · Blood · doi:10.1182/blood-2005-03-1158 · Cited by 319
Molecular sequelae of histone deacetylase inhibition in human malignant B cells
Mitsiades, N., Mitsiades, C. S., Richardson, P. G., McMullan, C., Poulaki, V., Fanourakis, G., Schlossman, R., Chauhan, D., Munshi, N. C., Hideshima, T., et al. (2003) · Blood · doi:10.1182/blood-2002-11-3514 · Cited by 294
Self-citation
Cited by
The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia
Leleu, X. P., Jia, X., Runnels, J. M., Ngo, H. T., Moreau, A., Farag, M., Spencer, J. A., Pitsillides, C. M., Hatjiharissi, E., Roccaro, A. M., et al. (2007) · Blood · doi:10.1182/blood-2007-05-092098 · Cited by 144
Self-citationCellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease
Arnold, S. E., Louneva, N., Cao, K., Wang, L.-S., Han, L.-Y., Wolk, D. A., Negash, S., Leurgans, S. E., Schneider, J. A., Buchman, A. S., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.004 · Cited by 123
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia
Roccaro, A. M., Sacco, A., Chen, C., Runnels, J. M., Leleu, X. P., Azab, F., Azab, A. K., Jia, X., Ngo, H. T., Melhem, M. R., et al. (2008) · Blood · doi:10.1182/blood-2008-09-178228 · Cited by 116
Self-citationTargeting NF-κB in Waldenstrom macroglobulinemia
Leleu, X. P., Eeckhoute, J., Jia, X., Roccaro, A. M., Moreau, A.-S., Farag, M., Sacco, A., Ngo, H. T., Runnels, J. M., Melhem, M. R., et al. (2008) · Blood · doi:10.1182/blood-2007-09-115170 · Cited by 109
Self-citationThe cellular origin and malignant transformation of Waldenström macroglobulinemia
Paiva, B., Corchete, L. A., Vídriales, M., García‐Sánz, R., Pérez, J. J., Aires‐Mejía, I., Sánchez, M.-L., Bárcena, P., Alignani, D., Jiménez, C., et al. (2015) · Blood · doi:10.1182/blood-2014-09-602565 · Cited by 109
Metadata
- Authors
- Hatjiharissi, E., Ngo, H., Leontovich, A. A., Leleu, X., Timm, M., Melhem, M., George, D., Lu, G., Ghobrial, J., Alsayed, Y., Zeismer, S., Cabanela, M., Nehme, A., Jia, X., Moreau, A. S., Treon, S. P., Fonseca, R., Gertz, M. A., Anderson, K. C., Witzig, T. E., & Ghobrial, I. M.
- Affiliations
- Harvard University (US)
- Mayo Clinic (US)
- VA Pittsburgh Healthcare System (US)
- University of Pittsburgh (US)
- 2Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota;
- ORCID
- Venue
- Cancer Research
- Published
- 2007-04-15
- Volume
- 67
- Issue
- 8
- Pages
- 3777-3784
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2043145911
- Cited by
- 61
- References
- 34
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2020: 1 · 2019: 4 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 5
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
- Keywords
- Waldenström macroglobulinemia, protein expression profiling, bone marrow, cyclin-dependent kinases, apoptosis regulators, histone deacetylase, HSP90, signaling pathway dysregulation, therapeutic target
- MeSH terms
- Aged, Bone Marrow Cells, Female, Humans, Hydroxamic Acids, Lymphocytes, Waldenstrom Macroglobulinemia, Male, Middle Aged, Plasma Cells, Reproducibility of Results, Benzoquinones, Apoptosis, HSP90 Heat-Shock Proteins, Proteomics, Lactams, Macrocyclic, Cell Growth Processes, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proteomic Analysis of Waldenstrom Macroglobulinemia. https://app.cochat.ai/papers/10.1158/0008-5472.can-06-3089
- The paper
- Hatjiharissi, E., Ngo, H., Leontovich, A. A., Leleu, X., Timm, M., Melhem, M., George, D., Lu, G., Ghobrial, J., Alsayed, Y., Zeismer, S., Cabanela, M., Nehme, A., Jia, X., Moreau, A. S., Treon, S. P., Fonseca, R., Gertz, M. A., Anderson, K. C., . . . Ghobrial, I. M. (2007). Proteomic Analysis of Waldenstrom Macroglobulinemia. Cancer Research. https://doi.org/10.1158/0008-5472.can-06-3089
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.